index - Myasthenia Gravis: étiologie, physiopathologie & approches thérapeutiques

Dernières publications

Chiffres clés

54 Publications avec texte intégral

Open Access

46 %

Mots clés

Interferon type-I Interféron de type I Exercise Complete Freund's adjuvant Immunology and Microbiology Section Experimental autoimmune myasthenia gravis EAMG Glucocorticoids Lamin A/C nuclei Immune response Il-23 Acetylcholine receptor Quality of life Cytokines Inflammatory cytokines COX2 Myasthénie grave Anticorps monoclonal Autoimmune disease MYB Experimental models Early-onset myasthenia gravis Max Maladie auto-immune PBMC Experimental mouse models Macrophages AChR antibodies COVID-19 Interferon de type I Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype Ferrites Interferon IFN Chemokine Acides nucléiques endogènes Acetylcholine receptor antibodies Acetylcholine receptors Thymoma Transcriptome Conduction disease Thymus Myasthenia gravis DICER Autoimmune diseases CTCF Th17 cells Immune regulation Genetic associations Gender Interleukin 23 Follicular hyperplasia Interleukine-23 Interferon type I CD31 B cells Cardiomyopathy CCL21 Disease susceptibility FMR1 Interferon-β MG patients Centres germinatifs ectopiques Antimir-150 Autoimmunity Ectopic germinal centers Heart failure Immunity Human myoblasts Endogenous nucleic acids Chemokines BAFF Myasthenia Gravis MG Cellules th17 Mass cytometry CyTOF Gd T cells Myoblasts Etiology Fragile X syndromes Germinal centers Chronicity Immunotherapy Innate immunity Adaptive immunity LMNA CXCL13-CXCR5 Neuromuscular junction Germinal center Genetics Chronic inflammation M3243AG Interferon Animal models Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration Experimental autoimmune myasthenia gravis Long-term follow-up Thymic epithelial cells Age Inflammation Interferonopathy Clinical cell transplantation Auto-immunité